Drosera composé

Country: Svizzera

Lingwa: Ġermaniż

Sors: Swissmedic (Swiss Agency for Therapeutic Products)

Ixtrih issa

Ingredjent attiv:

Kupfer metallic, C3, 10.0 %; Arnica montana, C3, 10.0 %; Atropa belladonna, C3, 10.0 %; Drosera, C3, 10.0 %; Artemisia china, C3, 10.0 %; Solidago virgaurea, C1, 10.0 %; Cephaelis ipecacuanha, C3, 10.0 %; Corallium rote, C3, 10.0 %; Eisen-metallic, C3, 10.0 %; Dactylopius coccus, C3, 10.0 %

Disponibbli minn:

Boiron SA

INN (Isem Internazzjonali):

Copper metallic, C3, 10.0 %; Arnica montana, C3, 10.0 %; Atropa belladonna, C3, 10.0 %; Drosera, C3, 10.0 %; Artemisia china, C3, 10.0 %; Solidago virgaurea, C1, 10.0 %; Cephaelis ipecacuanha, C3, 10.0 %; Corallium red, C3, 10.0 %; Iron metallic, C3, 10.0 %; Dactylopius coccus, C3, 10.0 %

Dożaġġ:

D

Għamla farmaċewtika:

Tropfen / Spray, Globuli, Tabletten

Kompożizzjoni:

Arnica montana, C3, 10.0 %; Cuprum metallicum, C3, 10.0 %; Atropa belladonna, C3, 10.0 %; Drosera, C3, 10.0 %; Solidago virgaurea, C1, 10.0 %; Cephaelis ipecacuanha, C3, 10.0 %; Artemisia cina, C3, 10.0 %; Corallium rubrum, C3, 10.0 %; Ferrum metallicum, C3, 10.0 %; Dactylopius coccus, C3, 10.0 %

Rotta amministrattiva:

oral

Grupp terapewtiku:

homöopathisch

Dokumenti f'lingwi oħra

Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Franċiż 26-05-2024
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Franċiż 26-05-2024

Ara l-istorja tad-dokumenti